These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12954176)

  • 21. Pharmacokinetics of isosorbide mononitrate in a new sustained release oral form in comparison with a conventional formulation.
    Gandini R; Cunietti E; Assereto R; Castoldi D; Tofanetti O; Baggio E
    Arzneimittelforschung; 1987 Jul; 37(7):836-9. PubMed ID: 3675680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factorial design-based optimization of the formulation of isosorbide-5-mononitrate microcapsules.
    Farivar M; Kaş HS; Oner L; Hincal AA
    J Microencapsul; 1993; 10(3):309-17. PubMed ID: 8377088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-acting isosorbide mononitrate.
    Prakash A; Markham A
    Drugs; 1999 Jan; 57(1):93-9; discussion 100. PubMed ID: 9951954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin.
    Kanagale P; Lohray BB; Misra A; Davadra P; Kini R
    AAPS PharmSciTech; 2007 Jul; 8(3):E53. PubMed ID: 17915803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
    Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
    Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
    Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
    Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An extensive study on isosorbide-5-mononitrate acid adducts for quantification in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry and its application to bioequivalence sample analysis.
    Jain DS; Subbaiah G; Sanyal M; Shrivastav PS; Pal U; Ghataliya S; Kakad A; Bhatt J; Munjal V; Patel H; Shah S
    Rapid Commun Mass Spectrom; 2006; 20(19):2921-31. PubMed ID: 16941726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.
    Schneider W; Menke G; Heidemann R; Satter P; Kaltenbach M; Rietbrock N
    Eur J Clin Pharmacol; 1990; 38(2):145-7. PubMed ID: 2338111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate.
    Liu Y; Liu S; Dai Q
    Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):55-60. PubMed ID: 19122316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
    Waller DG
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetic profile and bioavailability of a new pharmaceutical formulation of isosorbide-5-mononitrate sustained-release formulation].
    Skutta T; Böttcher B; Brandt L
    Arzneimittelforschung; 1989 Apr; 39(4):507-11. PubMed ID: 2751738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
    Gunasekara NS; Noble S
    Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization and evaluation of time-dependent tablets comprising an immediate and sustained release profile using artificial neural network.
    Xie H; Gan Y; Ma S; Gan L; Chen Q
    Drug Dev Ind Pharm; 2008 Apr; 34(4):363-72. PubMed ID: 18401778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained-release isosorbide mononitrate (50 mg): optimization of a once-daily dosage form for long-term treatment of angina pectoris.
    Bonn R
    Am J Cardiol; 1988 Mar; 61(9):12E-14E. PubMed ID: 3348135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on preparation of isosorbide-5-mononitrate pulsatile controlled-release pellets and various influence factors].
    Wang R; Huang G; Fang Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):885-8. PubMed ID: 18788301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multiple dose pharmacokinetic and bioavailability studies of oral sustained release and conventional formulations of isosorbide-5-mononitrate in healthy volunteers].
    Zhang Q; Huang X; Ji P; Fu L; Yan B; Wei S
    Yao Xue Xue Bao; 1998 May; 33(5):373-8. PubMed ID: 12017006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended-release isosorbide mononitrate for angina.
    Med Lett Drugs Ther; 1994 Feb; 36(915):13-4. PubMed ID: 8283957
    [No Abstract]   [Full Text] [Related]  

  • 39. A pharmacokinetic model for isosorbidedinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate.
    Smith D; Aldrich W; Dey M; Enever R; Warner R; Weierstall R
    Drug Metab Dispos; 1990; 18(4):429-34. PubMed ID: 1976063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil.
    Philip AK; Pathak K; Shakya P
    Eur J Pharm Biopharm; 2008 Jun; 69(2):658-66. PubMed ID: 18206358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.